GRACE :: Lung Cancer

Using Non/Off-Targeted Therapies in Targeted Lung Cancer Populations

Acquired Resistance Forum Video #6: Dr. Nate Pennell of the Cleveland Clinic discussed the other options available to patients with ALK, ROS1 and EGFR lung cancer, such as chemotherapy, Avastin, and immunotherapy.


Clinical Trial Design & Development of Highly Targeted Agents in the Molecular Era

Acquired Resistance Forum Video #5: Dr. Gideon Blumenthal of the US Food and Drug Administration (FDA) discussed the FDA process for approving targeted therapies.


Questions & Answers with Drs. Riely, Weiss and Sequist; Moderated by Dr. West

Acquired Resistance Forum Video #4: The first three speakers at the Acquired Resistance in Lung Cancer Patient Forum sat for a moderated Q&A with Dr. Jack West. 


Repeat Biopsies & the Potential Value of Biologically-Informed Acquired Resistance Therapy

Acquired Resistance Forum Video #3: Dr. Lecia Sequist of Massachusetts General Hospital detailed why doctors started doing repeat biopsies for patients receiving targeted therapies and how they help patients and doctors determine next steps in treatment.


Life After 1st Line Targeted Therapy: What Next?

Acquired Resistance Forum Video #2: Dr. Jared Weiss of the University of North Carolina addressed the Acquired Resistance in Lung Cancer Patient Forum with information on what patients’ options are when their ALK, ROS1 or EGFR lung cancer progresses. September 2014


Ask Us, Q&A
Lung/Thoracic Cancer Expert Content

Archives

GRACE Website Rebuild

Acquired Resistance Forum Videos

 

Watch ALK+ Lung Cancer Forum Videos

Join the GRACE Faculty

Breast Cancer Blog
Pancreatic Cancer Blog
Kidney Cancer Blog
Bladder Cancer Blog
Head/Neck Cancer Blog

Subscribe to the GRACEcast Podcast on iTunes

Email Newsletter icon, E-mail Newsletter icon, Email List icon, E-mail List icon

Subscribe to
GRACE Notes
   (Free Newsletter)

Other Resources

ClinicalTrials.gov


Biomedical Learning Institute

PeerView Press - Curriculum-Based Learning Activities